Base
N0658532009-07-06New YorkClassification

The tariff classification of Conivaptan Hydrochloride (CAS-168626-94-6) in bulk form, from Japan

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-05-09 · Updates monthly

Summary

The tariff classification of Conivaptan Hydrochloride (CAS-168626-94-6) in bulk form, from Japan

Ruling Text

N065853 July 6, 2009 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2933.99.7500 Mr. Eric Rock Katten Muchin Rosenman LLP 525 W. Monroe Street Chicago, IL 60661-3693 RE: The tariff classification of Conivaptan Hydrochloride (CAS-168626-94-6) in bulk form, from Japan Dear Mr. Rock: In your letter dated June 15, 2009, you requested a tariff classification ruling on behalf of your client, Astellas U.S. Technologies, Inc. The subject product, Conivaptan Hydrochloride, is a nonpeptide, dual antagonist of arginine vasopressin (AVP) V1A and V2 receptors. It is indicated for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients. The applicable subheading for the Conivaptan Hydrochloride in bulk form will be 2933.99.7500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Other: Other: Aromatic or modified aromatic: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division